M. Shao

Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates

R. Ward, J. Bean, J. Clements, 2006, Journal of Virology.

Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.

D. Bernstein, D. Sack, V. Smith, 2006, The Journal of infectious diseases.

Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.

L. Miles, J. Bean, S. Salisbury, 2007, Arthritis and rheumatism.

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

Qing Ma, M. Mitsnefes, K. Mori, 2005, The Lancet.

Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection.

R. Ward, J. Bean, J. Clements, 2007, Vaccine.